Clinical Trial of Low Density Lipoprotein-Apheresis for Treatment of Diabetic Gangrene

Internal Medicine

Volumn 36, Issue 12, 1997, Pages 898-902

  Iizuka, Takashi ^a   Takeda, Haruyo ^a   Inoue, Hiromi ^a   Miyamoto, Terukazu ^a   Ito, Hiroko ^a   Omura, Masao ^a   Tsuji, Hiroyuki ^a   Chiba, Shyozo ^a   Nishikawa, Tetsuo ^a  

^a YOKOHAMA ROSAI HOSPITAL   (Japan)

Author keywords

Foot gangrene; Low density lipoprotein (LDL) apheresis; Non insulin dependent diabetes mellitus (NIDDM)

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; APHERESIS; ARTICLE; BLOOD; CASE REPORT; CLINICAL TRIAL; DIABETIC FOOT; HUMAN; MALE; METHODOLOGY; TREATMENT OUTCOME;

AGED; BLOOD COMPONENT REMOVAL; CHOLESTEROL, LDL; DIABETIC FOOT; HUMANS; MALE; TREATMENT OUTCOME;

EID: 0031307912     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.898     Document Type: Article

References (12)

1. LoGerfo FW, Coffman JD. Current concepts. Vascular and microvascular disease of the fool in diabetes. Implications for foot care. N Engl J Med 311: 1615, 1984.
2. Debridge L, Appleberg M, Reeve TS. Factors associated with development of foot lesions in the diabetic. Surgery 93: 78, 1980.
3. McMillan DE. Plasma protein changes, blood viscosity, and diabetic microangiopathy. Diabetes 25: 858, 1976.
4. Uno H, Ueki Y, Murashita J, Miyake S, Tominaga Y, Eguchi K, Yano K. Removal of LDL from plasma by adsorption reduces adhesion molecules on mononuclear cells in patients with arteriosclerotic obliterans. Atherosclerosis 116: 93, 1995.
5. Pecoraro RE, Ahroni JH, Boyko EJ, Stensel VL. Chronology and determinants of tissue repair in diabetic lower-extremity ulcers. Diabetes 40: 1305, 1991.
6. Steinberg D, Parhasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 320: 915, 1989.
7. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801, 1993.
8. Bambauer R, Schiel R, Keller HE, Latza R. LDL-apheresis in two patients with extremely elevated lipoprotein (a) levels. Int J Artif Organs 18: 286, 1995.
9. Kritz H, Sinzinger H. Atherosclerotic lesions in humans-plaque stabilization and regression. Wien Klin Wochenschr 107: 555, 1995.
10. Rubba P, Iannuzzi A, Postiglione A, Scarpato N, Montefusco S, Gnasso A, Nappi G, Cortese C, Mancini M. Hemodynamic change in the peripheral circulation after repeat low density lipoprotein apheresis in familial hypercholesterolemia. Circulation 81: 610, 1990.
11. Tasaki H, Tsuda Y, Yamashita K, Toyokawa T. Removal of plasma fibrinogen by LDL apheresis. Jpn J Apheresis 15 Suppl: S55, 1996 (Abstract).
12. Ueki Y, Murashima J, Matsunaga Y, Tominaga Y, Miyake S. Generated bradykinin by LDL adsorption induces serum NO in patients with atherosclerotic obliterance. Jpn J Apheresis 15 Suppl: S56, 1996 (Abstract).